top
Please input keywords
Order
*Country
United States
China
France
Germany
Netherlands
United Kingdom
Japan
South Korea
Israel
Australia
Hong Kong, China
New Zealand
Russia
Singapore
Taiwan, China
India
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua & Barbuda
Argentina
Armenia
Aruba
Ascension Island
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia & Herzegovina
Botswana
Brazil
British Indian Ocean Territory
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Canary Islands
Cape Verde
Caribbean Netherlands
Cayman Islands
Central African Republic
Ceuta & Melilla
Chad
Chile
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo - Brazzaville
Congo - Kinshasa
Cook Islands
Costa Rica
Côte d’Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czechia
Denmark
Diego Garcia
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hungary
Iceland
Indonesia
Iran
Iraq
Ireland
Isle of Man
Italy
Jamaica
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau, China
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar (Burma)
Namibia
Nauru
Nepal
New Caledonia
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territories
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Islands
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Rwanda
Samoa
San Marino
São Tomé & Príncipe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Sint Maarten
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia & South Sandwich Islands
South Sudan
Spain
Sri Lanka
St. Barthélemy
St. Helena
St. Kitts & Nevis
St. Lucia
St. Martin
St. Pierre & Miquelon
St. Vincent & Grenadines
Sudan
Suriname
Svalbard & Jan Mayen
Swaziland
Sweden
Switzerland
Syria
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad & Tobago
Tristan da Cunha
Tunisia
Turkey
Turkmenistan
Turks & Caicos Islands
Tuvalu
U.S. Outlying Islands
U.S. Virgin Islands
Uganda
Ukraine
United Arab Emirates
United Nations
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Wallis & Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-hMFAP5 mice
Strain Name C57BL/6N-Mfap5tm1(MFAP5)Bcgen/Bcgen Common Name  B-hMFAP5 mice
Background C57BL/6N Catalog number 112885
Aliases 
AAT9, MAGP-2, MAGP2, MFAP-5, MP25
Description

  • MFAP5 is the gene that encodes the human MAGP-2 protein. Microfibril associated glycoproteins 1 and 2 (MAGP-1, MAGP-2) are the protein components of extracellular matrix microfibril. These proteins interact with fibrin, the core component of microfibril, affecting the function of vertebrate microfibril. MAGPs regulates Notch signaling in conjunction with TGFβ and BMP. MAGP-2 has also been shown to be an important biomarker for several human cancers. MFAP5 is basically not expressed in tumor tissues, but only expressed in tumors of about 10% of endometrial cancer patients. However, MFAP5 expression is elevated in many tumor-associated fibroblasts (CAFs), including non-small cell lung cancer, pancreatic cancer, ovarian cancer, prostate cancer, and breast cancer. 
  • Protein expression analysis: Human MFAP5 was detectable in herat, uterus, ovary, bladder and fat of homozygous B-hMFAP5 mice, but not in wild-type mice.
  • mRNA expression analysis: Mouse Mfap5 was only detectable in uterus of wild-type C57BL/6 mice. Human MFAP5 was detectable in uterus of homozygous B-hMFAP5 mice. 

Protein expression analysis


from clipboard

Western blot analysis of MFAP5 protein expression in homozygous B-hMFAP5 mice. Various tissue lysates were collected from wild-type C57BL/6 mice (+/+) and homozygous B-hMFAP5 mice (H/H), and then analyzed by western blot with species-specific anti-MFAP5 antibody (Abcam, ab203828). 40 μg total proteins were loaded for western blotting analysis. MFAP5 was detected in heart, uterus, ovary, bladder and fat of homozygous B-hMFAP5 mice, but not in wild-type mice.

mRNA expression analysis

from clipboard

Strain specific analysis of MFAP5 mRNA expression in wild-type C57BL/6 mice and B-hMFAP5 mice by RT-PCR. Uterus RNA were isolated from wild-type C57BL/6 mice (+/+) and homozygous B-hMFAP5 mice (H/H), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse or human MFAP5 primers. Mouse Mfap5 mRNA was detectable in wild-type mice. Human MFAP5 mRNA was detectable only in homozygous B-hMFAP5 mice, but not in wild-type mice.